Listed SME IPO QLINEBIOTECH

Q-Line Biotech IPO GMP & Allotment

Q-Line Biotech is a SME IPO with a price band of Rs 326.00 to Rs 343.00 that listed on 29 May 2026 at a listing gain of +31.78%. Track its full GMP history, subscription data and listing details here.

IPO Price Band
₹326.00 - ₹343.00
Lot Size
400 Shares
Bidding Closes
25 May 2026
Listing Date
29 May 2026
Quick Answer & Highlights

Q-Line Biotech IPO GMP Today & Key Takeaways

Last updated: 26 May 2026

Q-Line Biotech IPO officially listed on 29 May 2026 at Rs 452.00, delivering a +31.78% listing gain compared to its issue price of Rs 343.00. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹109.

Key Metric Figure Status / Context
Current GMP ₹109 +31.78% vs upper band (26 May 2026)
Est. Listing Price ₹452.00 +31.78% Est. Listing Gain
Price Band ₹326.00 - ₹343.00 SME IPO
Retail Minimum Investment ₹2,74,400 2 Lot (400 Shares)
Bidding Window 21 May 2026 – 25 May 2026 Listed
Allotment & Listing Dates Allotment: 26 May 2026 Listing: 29 May 2026
Will you apply for this IPO?
Is this GMP accurate?
Did you get allotted this IPO?
IPO Details

Complete IPO information

Q-Line Biotech IPO Details and Specifications
IPO Open Date 21 May 2026
IPO Close Date 25 May 2026
IPO Price Band ₹326.00 - ₹343.00
Lot Size 400 Shares
Current GMP ₹109
Estimated Listing Gain +31.78%
Issue Size -
Fresh Issue -
Issue Type SME
IPO Listing NSE, BSE
Retail Quota TBA
Registrar TBA
Overall Subscription 50.82x
Minimum Investment ₹2,74,400
DRHP Draft Prospectus PDF
RHP Draft Prospectus -
Analysis

IPO Snapshot & Investor Takeaways

At the upper end of its price band, Q-Line Biotech is priced at ₹343 per share. With a minimum lot size of 400 shares, a retail investor applying for one lot would need approximately ₹2,74,400 to participate in this SME issue.

The latest recorded Grey Market Premium for Q-Line Biotech stands at ₹109, implying an estimated listing gain of around 31.78% over the issue price if it holds until listing. This is down ₹24 from its previously recorded level. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.

As of the latest update, Q-Line Biotech's IPO was subscribed 50.82x overall, with a category-wise breakdown of Retail 47.12x, QIB 25.34x.

SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.

Timeline

IPO roadmap at a glance

✓
Bidding Opens 21 May 2026
✓
Bidding Closes 25 May 2026
✓
Allotment 26 May 2026
✓
Listing 29 May 2026
Q-Line Biotech IPO Timeline and Important Dates Schedule
Event / Milestone Scheduled Date Status
Bidding Opens 21 May 2026 Completed
Bidding Closes 25 May 2026 Completed
Allotment 26 May 2026 Completed
Listing 29 May 2026 Completed
Grey Market Premium

Daily GMP status

Q-Line Biotech IPO Daily Grey Market Premium (GMP) Trend & Price History
Date GMP Change Gain
26 May 2026 ₹101.00 -₹24.00 29.45%
25 May 2026 ₹125.00 +₹14.50 36.44%
20 May 2026 ₹110.50 - 32.22%
Swipe to see more →
Market Lot

Application size breakdown

Q-Line Biotech IPO Market Lot & Application Breakdown
Category Lots Shares Amount
Retail Minimum 2 Lot 800 ₹2,74,400
Retail Maximum 2 Lot 800 ₹2,74,400
S-HNI Minimum 3 Lot 1,200 ₹4,11,600
S-HNI Maximum 7 Lot 2,800 ₹9,60,400
B-HNI Minimum 8 Lot 3,200 ₹10,97,600
Swipe to see more →
Fund Utilization

Objects of the Issue & Official Documents

Analysis

IPO Reservation

Investor Category Share Offered Shares (%)
Anchor Investor – Shares -%
QIB (Ex. Anchor) 29,69,200 Shares 50%
NII Shares Offered 8,91,600 Shares 15%
Retail Shares Offered 20,79,200 Shares 35%
Analysis

Q-Line Biotech IPO Anchor Investors

Particulars Details
Anchor Bidding Date 2026
Anchor Investors List PDF
Shares Offered [.] Shares
Anchor Size [.] Cr.
Lock-in Period End Date 50% Shares (30 Days) 2026
Lock-in Period End Date 50% Shares (90 Days) 2026
Analysis

ಕ್ಯೂ-ಲೈನ್ ಬಯೋಟೆಕ್ IPO Dates

Particular Dates
IPO Open Date 21 May 2026
IPO Close Date 25 May 2026
Basis of Allotment 26 May 2026
Refunds -
Credit to Demat Account -
IPO Listing Date 29 May 2026

Note: The timeline for ಕ್ಯೂ-ಲೈನ್ ಬಯೋಟೆಕ್ IPO is tentative and subject to change.

Analysis

Promoters and Holding Pattern

The promoters of the company are Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty and Abhay Agrawal.

Particular Shares % Share
Promoter Holding Pre Issue 1,70,74,999 96.77%
Promoter Holding Post Issue 2,33,28,199 -%
Analysis

ಕ್ಯೂ-ಲೈನ್ ಬಯೋಟೆಕ್ Objects of the Issue & Utilisation of Proceeds

To Be Updated Soon

Analysis

About Q-Line Biotech IPO

Since its incorporation in 2013, Q-Line Biotech has been involved in the healthcare and diagnostic industry. The firm is known for manufacturing and supplying In-Vitro Diagnostic (IVD) products, medical diagnostic equipment, reagents, rapid test kits, and pathology instruments. The firm has been known to offer high-quality products and services at an affordable price range. 
 

Q-Line Biotech has over 15 years of experience in the diagnostic industry and has served 150+ national and international clients. Moreover, the company also has 12 years of experience in developing and manufacturing various products. Its product range includes haematology, POC testing, clinical chemistry, molecular diagnostics, rapid tests, ELISA, and special diagnostics.

Analysis

ಕ್ಯೂ-ಲೈನ್ ಬಯೋಟೆಕ್ Company Financials

To Be Updated Soon

Analysis

ಕ್ಯೂ-ಲೈನ್ ಬಯೋಟೆಕ್ Company Valuation – FY2026

To Be Updated Soon

Analysis

ಕ್ಯೂ-ಲೈನ್ ಬಯೋಟೆಕ್ IPO Peer Group Comparison

To Be Updated Soon

Analysis

IPO Lead Managers aka Merchant Bankers

  • Hem Securities Ltd.
  • Share India Capital Services Pvt. Ltd.
Comparison

Compare Q-Line Biotech IPO with similar IPOs

FAQ

Q-Line Biotech IPO FAQs

Q-Line Biotech IPO GMP today is Rs 109. Investors can use this GMP along with price band and subscription status for a better IPO review.
Based on the latest Grey Market Premium (GMP) of Rs 109 and an issue price of Rs 343, the estimated listing price for Q-Line Biotech IPO is Rs 452.00 (approx 31.78% listing gain). Actual listing price is determined by market demand on the listing day.
Q-Line Biotech IPO price band is Rs 326.00 to Rs 343.00. Check the latest issue price, lot size and GMP together before applying.
Q-Line Biotech IPO open date is 21 May 2026, close date is 25 May 2026, and listing date is 29 May 2026.
Q-Line Biotech IPO lot size is 400 shares. The minimum retail investment is Rs 2,74,400.
Q-Line Biotech is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Q-Line Biotech IPO subscription status currently shows Retail 47.12x, QIB 25.34x, Overall 50.82x.
Q-Line Biotech IPO issue size is TBA and the expected allotment date is 26 May 2026.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
Community discussion

Comments

Share a useful question or insight about Q-Line Biotech.

Loading comments...

Leave a comment

Your email address will not be published. All comments and replies are reviewed before appearing.

Keep Exploring

Similar Recent IPOs

Related Topics
Q-Line Biotech IPOQ-Line Biotech GMPQ-Line Biotech IPO GMPQ-Line Biotech IPO GMP todayQ-Line Biotech grey market premiumQ-Line Biotech price bandQ-Line Biotech subscription statusQ-Line Biotech allotment statusQ-Line Biotech listing dateQ-Line Biotech lot sizeQ-Line Biotech IPO reviewQ-Line Biotech IPO listing gain estimateQ-Line Biotech GMP calculatorQ-Line Biotech IPO 2026